Antibody Directed Enzyme Prodrug Therapy
The drug is designed to be inactive (a prodrug) until it is converted by an enzyme, which is the targeting agent. The enzyme is coupled to an antibody that directs it to the tissue of interest. When the enzyme arrives at the tissue, the prodrug is activated only at that site, sparing other tissues from potentially toxic side effects.
(14 Nov 1997)
|Bookmark with:||word visualiser||Go and visit our forums|